1-3 of 3
Qi Chao
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML)

Patrick P. Zarrinkar, Ruwanthi N. Gunawardane, Merryl D. Cramer, Michael F. Gardner, Daniel Brigham, Barbara Belli, Mazen W. Karaman, Keith W. Pratz, Gabriel Pallares, Qi Chao, Kelly G. Sprankle, Hitesh K. Patel, Mark Levis, Robert C. Armstrong, Joyce James, Shripad S. Bhagwat
Journal: Blood
Blood (2009) 114 (14): 2984–2992.
https://doi.org/10.1182/blood-2009-05-222034
Published: 2009
Includes: Supplemental data
Journal Articles

Mechanism of Action and Safety of Second Generation Analogs of SDX-101 (R-Etodolac).

Lorenzo M. Leoni, Ph.D., Brian Crain, Brandi Bailey, Mimi Phillips, Heather Bendall, Ph.D., Qi Chao, Ph.D., Jack Reifert, Christina Niemeyer, Ph.D., Gary Elliott, Ph.D.
Journal: Blood
Blood (2004) 104 (11): 3411.
https://doi.org/10.1182/blood.V104.11.3411.3411
Published: 2004
Journal Articles

Deoxyadenosine analogs induce programmed cell death in chronic lymphocytic leukemia cells by damaging the DNA and by directly affecting the mitochondria

Davide Genini, Souichi Adachi, Qi Chao, David W. Rose, Carlos J. Carrera, Howard B. Cottam, Dennis A. Carson, Lorenzo M. Leoni
Journal: Blood
Blood (2000) 96 (10): 3537–3543.
https://doi.org/10.1182/blood.V96.10.3537
Published: 2000